Correlation Between Biofil Chemicals and Abrdn Bloomberg

Can any of the company-specific risk be diversified away by investing in both Biofil Chemicals and Abrdn Bloomberg at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofil Chemicals and Abrdn Bloomberg into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biofil Chemicals Pharmaceuticals and abrdn Bloomberg All, you can compare the effects of market volatilities on Biofil Chemicals and Abrdn Bloomberg and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofil Chemicals with a short position of Abrdn Bloomberg. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofil Chemicals and Abrdn Bloomberg.

Diversification Opportunities for Biofil Chemicals and Abrdn Bloomberg

-0.02

Correlation Coefficient

Biofil Chemicals  Abrdn Bloomberg

Good diversification

The 3 months correlation between Biofil and Abrdn is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Biofil Chemicals Pharmaceutica and abrdn Bloomberg All in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on abrdn Bloomberg All and Biofil Chemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofil Chemicals Pharmaceuticals are associated (or correlated) with Abrdn Bloomberg. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of abrdn Bloomberg All has no effect on the direction of Biofil Chemicals i.e., Biofil Chemicals and Abrdn Bloomberg go up and down completely randomly.

Pair Corralation between Biofil Chemicals and Abrdn Bloomberg

Assuming the 90 days trading horizon Biofil Chemicals Pharmaceuticals is expected to generate 5.34 times more return on investment than Abrdn Bloomberg. However, Biofil Chemicals is 5.34 times more volatile than abrdn Bloomberg All. It trades about 0.04 of its potential returns per unit of risk. abrdn Bloomberg All is currently generating about -0.05 per unit of risk. If you would invest  6,655  in Biofil Chemicals Pharmaceuticals on February 7, 2024 and sell it today you would earn a total of  100.00  from holding Biofil Chemicals Pharmaceuticals or generate 1.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	81.82%
Values	Daily Returns

Biofil Chemicals Pharmaceutica  vs.  abrdn Bloomberg All

Biofil Chemicals Pha

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Biofil Chemicals Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound forward indicators, Biofil Chemicals is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

abrdn Bloomberg All

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in abrdn Bloomberg All are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent fundamental indicators, Abrdn Bloomberg may actually be approaching a critical reversion point that can send shares even higher in June 2024.

Pair Trading with Biofil Chemicals and Abrdn Bloomberg

The main advantage of trading using opposite Biofil Chemicals and Abrdn Bloomberg positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofil Chemicals position performs unexpectedly, Abrdn Bloomberg can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abrdn Bloomberg will offset losses from the drop in Abrdn Bloomberg's long position.

The idea behind Biofil Chemicals Pharmaceuticals and abrdn Bloomberg All pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.